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Microdeletions Glu767(1-bp del), Thr967(1-bp del), and Leu1446(2-bp del) in the human USH2A gene have been
reported to cause Usher syndrome type II, a disorder characterized by retinitis pigmentosa (RP) and mild-to-severe
hearing loss. Each of these three frameshift mutations is predicted to lead to an unstable mRNA transcript that,
if translated, would result in a truncated protein lacking the carboxy terminus. Here, we report Cys759Phe, a novel
missense mutation in this gene that changes an amino-acid residue within the ﬁfth laminin–epidermal growth
factor–like domain of the USH2A gene and that is associated with recessive RP without hearing loss. This single
mutation was found in 4.5% of 224 patients with recessive RP, suggesting that USH2A could cause more cases of
nonsyndromic recessive RP than does any other gene identiﬁed to date.
The Usher syndromes (MIM 276901) are a group of
recessively inherited diseases affecting ∼12,000 people
in the United States alone (Boughman et al. 1983). Pa-
tients typically have progressive visual loss due to reti-
nitis pigmentosa (RP), as well as different levels of deaf-
ness or vestibular function (Smith et al. 1994). On the
basis of the severity of the sensorineural dysfunction,
Usher syndrome has been subcategorized into three dis-
tinct types and has been linked to 10 different loci
(types IA–IF, types IIA–IIC, and type III [Hereditary
Hearing Loss Home Page]). To date, only two Usher
genes, MYO7A and USH2A, have been cloned, and they
have been identiﬁed as responsible for Usher syndrome
types IB and IIA, respectively (Weil et al. 1995; Eudy et
al. 1998). In addition, mutations in MYO7A have been
found to cause dominant or recessive nonsyndromic
deafness (Liu et al. 1997a, 1997b; Weil et al. 1997). A
1.6-cM region of 11p, containing the locus responsible
for type IC (USH1C), appeared to segregate with reces-
sive deafness in a large consanguineous Indian family
(Jain et al. 1998).
To investigate whether USH2A could be involved in
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nonsyndromic RP, we analyzed a 154-bp genomic frag-
ment encompassing codon 759 by SSCP and direct ge-
nomic sequencing (for methods, see Hagstrom et al.
1998) in DNA samples from patients, using primers
(sense, ATGTTGGATGTGAGCCCTGC; antisense,
CAATTGGTGACATCTAACCC) based on the partial
USH2A sequence that has been published (Eudy et al.
1998). We evaluated 224 unrelated patients, mostly
from North America, who previously had been cate-
gorized as having recessive nonsyndromic RP. Ten of
the 224 patients carried a novel missense mutation,
Cys759Phe (TGCrTTC). In all 10 cases, this missense
mutation was associated with an isocoding change at
codon His752 (CATrCAC; ﬁg. 1A). Prior evaluations
of other recessive RP genes (PDEA, PDEB, CNGA1,
TULP1, RPE65, SAG, CRALBP, and/or RGR) in 7 of
these 10 patients did not uncover any pathogenic mu-
tations. Two of these 10 cases had the Cys759Phe mu-
tation homozygously. Next we analyzed the only other
regions of the USH2A gene with available PCR-primer
sequence information (bases 2854–2962 and bases
4251–4364 [Eudy et al. 1998]). We found that two of
the Cys759Phe carriers were compound heterozygotes
with both that allele and one of the previously reported
frameshift mutations, Glu767(1-bp del) or Leu1446 (2-
bp del). The association of the Cys759Phe allele with
recessive RP was investigated further by recruitment of
relatives from 6 of the 10 index patients who carried
this allele. In every family, including the families of the
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Figure 1 A, Nucleotide sequence of the region encompassing codons 751–761 in a normal control (top); in patient 003-203, who is
homozygous for both the missense change Cys759Phe and an isocoding change in codon 752 (middle); and in patient 003-126,who isheterozygous
for both changes (bottom). B, Schematic pedigrees of six families (6792, E685, 6705, 0994, 5666, and 5011) with recessive RP without hearing
loss segregating the Cys759Phe allele. Arrows point to index cases. Identiﬁcation numbers of the patients whose hearing was tested with
audiograms are below their genotypes. 1 = 2299delG (Glu767[1-bp del]); 2 = Cys759Phe; 3 = 4337-8delTC (Leu1446[2-bp del]); ncf = no
change found within the investigated regions. C, Primary structure of part of the USH2A protein. Lines are drawn between disulﬁde bridges
connecting cysteine residues of the ﬁfth LE motif (red lines) and the fourth and sixth LE motifs (green lines). An arrow points to residue 759,
which participates in one of the disulﬁde bridges.
two index cases who were compound heterozygotes for
the Cys759Phe mutation and one of the frameshift
mutations in USH2A mentioned above (ﬁg 1B), the
identiﬁed USH2A mutations segregated with RP, as
would be expected if they were pathogenic (summed
at recombination fraction ). ToLOD = 4.4 v = 0max max
determine whether Cys759Phe was speciﬁc for nonsyn-
dromic RP and not also associated with RP with deaf-
ness, we extended the survey to include 51 unrelated
patients with Usher type II and 190 normal control in-
dividuals. No patient with Usher type II carried the
Cys759Phe allele; one control carried it heterozygously.
The patients with recessive RP had previously been
asked to complete a questionnaire that included a ques-
tion about the status of their hearing. Of the 224
patients, 194 answered this question, and 37 of those
reported mild hearing impairment that was initially
interpreted as not clinically signiﬁcant. Nine of the 10
patients with the Cys759Phe mutation answered the
question, and none reported hearing impairment (the
compound heterozygote with both the Glu767[1-bp del]
and the Cys759Phe allele was among the 9 patients who
reported no hearing impairment; the other compound
heterozygote did not answer the question). There was
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Figure 2 Pure-tone air-conduction audiograms of four female (left) and four male (right) patients carrying the Cys759Phe mutation. The
data are the averages for the right and left ears. The patients’ identiﬁcation numbers and ages are to the right of each graph. The patients are
unrelated, except for 121-369 and 003-167, who are siblings. Patient 003-203 is a homozygote; the other cases are heterozygotes. The dark-
and light-gray areas are the hearing ranges (average values 1 SD) for normal individuals at age 48–59 and 60–69 years, respectively, reported
by Cruickshanks et al. (1998). Broken and dotted lines indicate the average  1 SD, respectively, of the audiograms for patients with Usher
type II (males  females) at age 40–49 (thinner lines) and 50–59 (thicker lines) years, on the basis of data published by Wagenaar et al. (1999).
The black arrowheads at the bottom right corners indicate values that are off the scale.
no statistically signiﬁcant association of the Cys759Phe
allele with reported hearing loss (0/37 vs. 9/157; 2x =
, ; by Fisher’s exact test). To conﬁrm1.12 P = .29 P = .21
their reported normal hearing status, 7 of the 10 index
patients with the Cys759Phe allele and 1 affected sibling
underwent pure-tone audiometry. Every patient had
hearing acuity within the normal range for age, and,
speciﬁcally, no patient had hearing impairment in the
published range found in patients with Usher type II who
were of comparable age (ﬁg. 2). Included among those
patients documented to have normal hearing were the
two compound heterozygotes with Cys759Phe and pre-
viously reported frameshift mutations, which indicates
that the frameshifts do not cause Usher type II, but only
nonsyndromic RP, if they are present together with the
newly identiﬁed missense mutation.
During the course of this study, we found that 14 of
the 51 patients with Usher type II heterozygously carried
the previously reported USH2A frameshift mutation
Glu767(1-bp del) (Eudy et al. 1998; Liu et al. 1999).
Nine of 224 patients with nonsyndromic RP also carried
this mutation heterozygously, and no control did. The
frequency of this allele in these groups was .14, .02, and
.00, respectively. Of the nine patients with nonsyndromic
RP who carried the Glu767(1-bp del) allele, eight an-
swered the question regarding subjective hearing loss.
Six of these eight patients reported hearing impairment;
one of the carriers who did not was the compound het-
erozygote with Cys759Phe who has been mentioned
above. Among patients with presupposed nonsyndromic
RP, the association of Glu767(1-bp del) with reported
hearing loss was statistically signiﬁcant (6/37 vs. 2/157;
, ; by Fisher’s exact test).2x = 13.34 P = .0002 P = .0007
Our data suggest that many patients with presumed non-
syndromic RP who report mild, subjective hearing im-
pairment actually have Usher syndrome type II.
The USH2A gene product is predicted to be a 171.5-
kD extracellular protein with 10 laminin–epidermal
growth factor (LE) and 4 ﬁbronectin type III motifs. The
residue affected by the Cys759Phe missense mutation
participates in a presumed disulﬁde bridge in the ﬁfth
LE motif in the USH2A protein sequence (ﬁg. 1C; Eudy
et al. 1998). On the basis of the Cys759Phe allele’s in-
ferred alteration of the protein, its association with re-
cessive RP, and its cosegregation with this disease, we
conclude that it is pathogenic. Other known genes caus-
ing nonsyndromic, recessive RP—such as rhodopsin, the
a subunit of rod cGMP-phosphodiesterase, the b subunit
of rod cGMP-phosphodiesterase, the rod cGMP-gated
cation channel, TULP1, CRALBP, RPE65, and arres-
tin—each account for 4% of recessive nonsyndromic
RP. The USH2A locus might account for an even greater
percentage of recessive RP, since the Cys759Phe allele
by itself accounts for ∼4.5% of cases.
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